Hospital pharmacy news, drug costs and specialty pharmacy trends
Becker’s reports on drug prices, shortages and the specialty pharmacy programs health systems are building. Coverage extends to 340B policy, pharmacy staffing and the distribution models.
Featured Content
The FDA has granted accelerated approval to Bristol Myers Squibb’s Zenbexus, the first FDA-approved cereblon E3 ligase modulator, or CELMoD,…